Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes
Author(s) -
Gjin Ndrepepa,
FranzJosef Neumann,
Maurizio Menichelli,
Isabell Bernlochner,
Gert Richardt,
Jochen Wöhrle,
Bernhard Witzenbichler,
Katharina Mayer,
Salvatore Cassese,
Senta Gewalt,
Erion Xhepa,
Sebastian Kufner,
Hendrik B. Sager,
Michael Joner,
Tareq Ibrahim,
KarlLudwig Laugwitz,
Heribert Schunkert,
Stefanie Schüpke,
Adnan Kastrati
Publication year - 2021
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.121.021418
Subject(s) - medicine , acute coronary syndrome , ticagrelor , clinical endpoint , prasugrel , antithrombotic , randomized controlled trial , hazard ratio , incidence (geometry) , cardiology , myocardial infarction , lower risk , single center , clinical trial , proportional hazards model , mortality rate , fibrinolytic agent
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom